The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease

Table 1

Patients’ characteristics.

Number		183
Diagnosis	UC	72
	CD	107
	Pouchitis	3
	IBD-U	1
Gender	Female	115
	Male	68
Age (years)	Median	24
	Mean	31.3
	Range	4–84
Physician global assessment	Remission	63
	Mild	85
	Moderate	32
	Severe	3
UC phenotype	E1	9
	E2	13
	E3	50
CD phenotype	Location
	Small bowel	44
	Colon	13
	SB-colon	50
	Upper GI	20
	Perianal	21
	Behavior
	Inflammatory	65
	Stricturing	26
	Fistulizing	16